 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff
August 29, 2012
Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
August 29, 2012 / Pharmacogenomics Reporter - Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
July 27, 2011 / Pharmacogenomics Reporter - Generation Health Tackles Slow Genetic Test Uptake by Unpacking CPT Codes, Planning Utility Studies
May 11, 2011 / Pharmacogenomics Reporter - CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
June 2, 2010 / Pharmacogenomics Reporter - CVS Caremark Takes Majority Stake in Generation Health; GBM CEO to Head CVS PBM
December 23, 2009 / Pharmacogenomics Reporter